Atlas Trials

A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

Clinical trial NCT06109649 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06109649
Sponsor
Clinuvel, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Vitiligo
Start date
2023-10-11
Primary completion
2025-12-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.